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Simona Iezzi* and Maurizio Fanciulli*
Laboratory of Epigenetics, Molecular Medicine Area, Regina Elena National Cancer Institute, Rome, Italy
The transcriptional cofactor Che-1/AATF is currently emerging as an important
component of the DNA damage response (DDR) machinery, the complex signaling
network that maintains genome integrity and prevents tumorigenesis. Moreover this
protein is involved in a wide range of cellular pathways, regulating proliferation and
survival in both physiological and pathological conditions. Notably, some evidence
indicates that dysregulation of Che-1/AATF levels are associated with the transformation
process and elevated levels of Che-1/AATF are required for tumor cell survival. It is for
these reasons that Che-1/AATF has been regarded as an attractive, still theoretical,
therapeutic target for cancer treatments. In this review, we will provide an updated
overview of Che-1/AATF activities, from transcriptional regulation to DDR.
Keywords: Che-1/AATF, DNA damage response, transcription, apoptosis, cell cycle regulation, cellular stress,
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Che-1/AATF at a Glance
More than 10 years ago human Che-1/AATF was identiﬁed by two diﬀerent groups as both an
RNA polymerase II binding protein and a gene downregulated upon TGF β induced diﬀerentiation
(Fanciulli et al., 2000; Lindfors et al., 2000).
The human Che-1/AATF gene is located on chromosome 17, a region of the genome that is
very rich in protein-coding genes, segmental duplications, and home to genes implicated in a wide
range of human genetic diseases, such asBRCA1 andTP53 (Zody et al., 2006). It is highly conserved
among eucaryotes and encodes for a protein of 558 aminoacids, whose expression is regulated by
a negative feedback mechanism in which Che-1/AATF is present on its own promoter exerting
an inhibitory eﬀect (Monaco et al., 2003). At the structural level, the protein is characterized by
the presence of an N-terminal acidic domain, a canonical leucine zipper, and three LXXLL motifs
for nuclear receptor binding. It also contains two nuclear and two putative nucleolar localization
signals (Fanciulli et al., 2000; Lindfors et al., 2000; Scott et al., 2011) and, at the cellular level Che-
1/AATF mostly shows a nuclear and nucleolar localization. However, a cytoplasmic localization
has also been reported in primary cerebellar granule neurons (Barbato et al., 2003; Di Certo et al.,
2007), hippocampal neurons (Guo and Xie, 2004), and mouse embryonic ﬁbroblasts (Höpker et al.,
2012).
Che-1/AATF is a Transcriptional Cofactor
Che-1/AATF’s ability to bind the RNA polymerase II in addition to the observation that its
rat ortholog exhibits transactivation activity (Page et al., 1999), suggested from the beginning
that Che-1/AATF could have been a transcriptional cofactor involved in the regulation of gene
expression by connecting speciﬁc transcription factors to the general transcriptional machinery.
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In fact, Che-1/AATF has been shown to interact with nuclear
hormone receptors in vitro and to enhance transactivation of
several steroid hormone receptors, alone or in cooperation with
histone acetyltransferase p300 (Leister et al., 2003). In addition,
it has also been reported that Che-1/AATF activity on andro-
gen receptor mediated transcription is enhanced by its inter-
action with the tumor suppressor protein TSG101 (Burgdorf
et al., 2004). Up until now, in addition to nuclear hormone
receptors, several transcription factors, including the retinoblas-
toma protein (pRb), p65, and STAT3 (Bruno et al., 2002, 2006;
Ishigaki et al., 2010), have been proven to interact with Che-
1/AATF, thereby involving it in multiple cellular processes. These
interactions are mostly regulated by post-translational modiﬁca-
tions, which provide a rapid and reversible manner to modulate
Che-1/AATF co-transcriptional activity in response to diﬀerent
stimuli (Table 1). In this regard, it is interesting to note that
this protein interacts with RNA polymerase II through the C-
terminal region of the subunit 11 (hRPB11; Fanciulli et al., 2000).
This subunit is encoded by a multigene family which produces,
along with the main form hRPB11a, proteins diﬀering in their C-
terminal domain, with diﬀerent binding abilities and diﬀerently
expressed in several tissues (Grandemange et al., 2001; Benga
et al., 2005). Thus, Che-1/AATF action on transcription may
depend on its binding of both transcription factors or diﬀerent
forms of hRPB11.
Che-1/AATF in Proliferation and Cell
Cycle Control
Che-1/AATF protein is ubiquitously expressed (Fanciulli et al.,
2000; Lindfors et al., 2000) and its expression is essential for
proliferation and survival since Traube (Che-1/AATF mouse
ortholog) knock out mice are embrionically lethal at the preim-
plantation state (Thomas et al., 2000).Moreover, mutant embryos
exhibit a signiﬁcant reduction in the total number of cells,
indicating Che-1/AATF’s involvement in cell cycle regulation.
Consistent with these data, Bruno et al. (2002) demonstrated
that Che-1/AATF promotes cell cycle progression by inhibiting
the growth suppression functions of the pRb protein. pRb exerts
its anti-proliferative functions by interacting with transcrip-
tion factors E2F and promoting the assembly of an inhibitory
complex containing histone deacetylases (i.e., HDAC1) on the
promoters of E2F-responsive genes, whose expression is essen-
tial for the transition G1/S (Dick and Rubin, 2013). Che-
1/AATF directly binds pRB and removes HDAC1 from the
Rb/E2F complex, allowing transcription and progression to the
S phase (Bruno et al., 2002). This activity may be modulated
by its interaction with IFT88/polaris, a centrosomal protein
that negatively regulates G1–S transition and inhibits Che-
1/AATF binding to pRb (Robert et al., 2007). Remarkably,
Che-1/AATF is hyperphosphorylated and accumulated during
the G1/S transition (Bruno et al., 2002), suggesting that post-
translational modiﬁcations may also regulate Che-1/AATF pro-
proliferative functions. In addition, it has been recently shown
that Che-1/AATF also participates in the control of mitotic
entry by localizing at interphase centrosomes and regulating
centrosome duplication and spindle formation (Sorino et al.,
2013).
Che-1/AATF is an Anti-Apoptotic
Factor
Along with its pro-proliferative role, Che-1/AATF also exhibits
strong anti-apoptotic activity. Indeed, the rat AATF protein
was originally identiﬁed for its ability to interact with and
antagonize the activity of Dlk/ZIP (ZIPK), a serine/threonine
kinase involved in the induction of apoptosis (Page et al.,
1999).
Up until now much of the information regarding the anti-
apoptotic function of Che-1/AATF derives from studies per-
formed in the neural tissue, where this protein seems to be
involved in the regulation of the apoptotic signaling in both
physiological and pathological conditions. Di Certo et al. (2007)
showed a direct interaction between Che-1/AATF and neu-
rotrophilin receptor interacting MAGE homolog “NRAGE,” an
inducer of cell-death during neuronal development. In particu-
lar, they demonstrated that Che-1/AATF counteracts NRAGE-
induced apoptosis, while NRAGE overexpression induces Che-
1/AATF degradation by targeting it to the ubiquitin–proteasome
pathways (Di Certo et al., 2007). Similarly, some evidence sug-
gests that Che-1/AATF anti-apoptotic activity is involved in
the neurodegeneration process associated with neurodegenera-
tive diseases, such as Alzheimer’s. This pathology is associated
with extracellular aggregates of the β-amyloid peptide (Aβ) and
intraneuronal ﬁbrillar tangles of the microtubule binding pro-
tein Tau (Crews and Masliah, 2010). It has been demonstrated
that Che-1/AATF can counteract neuronal degeneration induced
by Aβ by interacting with prostate apoptosis response-4 (par-4)
and blocking the par-4 mediated aberrant production and secre-
tion of the neurotoxic peptide (Xie and Guo, 2004). Moreover,
Che-1/AATF interacts with Tau in rat cerebellar granule neurons
where this interaction is modulated during neuronal apopto-
sis (Barbato et al., 2003). A further indication of Che-1/AATF
involvement in neurodegeneration is the demontration that it
interacts with and is a substrate of cyclin-dependent kinase
5 (Cdk5), a serine/threonine protein kinase, whose activity is
deregulated in neurodegenerative diseases (Buontempo et al.,
2008).
A protective role of Che-1/AATF has also been reported in
human kidney proximal tubule cells, where this protein has been
observed to counteract apoptotic cell death following induced-
renal injury by preserving mitochondrial function and reducing
oxidative damage (Xie and Guo, 2006).
However, a pro-apoptotic role of Che-1/AATF has been
recently reported. Ferraris et al. (2012) demonstrated that
Che-1/AATF overexpression enhances UV induced apopto-
sis by promoting phosphorylation and transactivational activ-
ity of the pro-apoptotic factor cJun, in a p53 indepen-
dent manner. Moreover, UV damage induces Che-1/AATF
redistribution from nucleolus to nucleoplasm, thus allow-
ing a direct Che-1/AATF-cJun interaction (Ferraris et al.,
2012).
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TABLE 1 | Che-1/AATF post-translational modifications.
Modification Residue Enzyme Function Reference
Phosphorylation S181 ATM Stabilization upon DNA damage; modulation of protein–protein interactions Bruno et al. (2006)
S141 S474 S508 Chk2 Stabilization upon DNA damage; modulation of protein–protein interactions Bruno et al. (2006)
T144 HIPK2 Degradation following apoptotic DNA damage De Nicola et al. (2014)
S316* S320* S321* Modulated upon autophagy inhibition Alayev et al. (2014)
T366* MK2 Nuclear translocation Höpker et al. (2012)
Cdk5 Buontempo et al. (2008)
Poly(ADP ribosyl)ation PARP-1 Stabilization upon DNA damage Bacalini et al. (2011)
Ubiquitination HDM2 Degradation following apoptotic DNA damage De Nicola et al. (2007)
Isomerization P145 Pin1 Prerequisite for ubiquitination and degradation De Nicola et al. (2007)
Che-1 and AATF genes were cloned independently by two different groups. They encode for the same protein but in GenBank their sequences differ in the total number
of aminoacids. AATF is reported as a protein composed of 560 aa while Che-1 of 558 aa. In order to avoid confusion we reported the position of the modified residue as
indicated in the literature and the sequence which is referred to. *indicates AATF sequence.
Che-1/AATF is Involved in the Cellular
Response to Different Kind of Stress
DNA Damage
An increasing number of studies indicate Che-1/AATF as an
important component of the DNA damage response (DDR), a
complex network of pathways that eucaryotic cells have evolved
tomaintain genome integrity and prevent tumorigenesis (Jackson
and Bartek, 2009; Lord and Ashworth, 2012). DDR coordi-
nates multiple factors that cooperate together to detect genomic
lesions, arrest cell cycle in order to allow repair, and promote
apoptosis or senescence if damage is too severe (Ciccia and
Elledge, 2010).
Upon DNA damage Che-1/AATF is extensively modiﬁed by
post-translational modiﬁcations aﬀecting its localization, half-life
and interacting partners. It has been demonstrated that check-
point kinases MK2, ATM, Chk2 can phosphorylate and activate
this protein (Höpker et al., 2012; Bruno et al., 2006). Höpker
et al. (2012) have shown that DNA damage promotes Che-
1/AATF phosphorylation by checkpoint kinase MK2 at residue
T366. This modiﬁcation induces translocation of Che-1/AATF
from the cytoplasm to the nucleus where it inhibits transcription
of p53 dependent proapoptotic genes, such as Puma, Bax, and
Bak (Höpker et al., 2012). On the other hand, phosphorylation
through ATM and Chk2 leads to Che-1/AATF stabilization and
accumulation by increasing its resistance to proteasome degra-
dation (Bruno et al., 2006). Moreover, these latter modiﬁcations
greatly aﬀect Che-1/AATF functions, acting as a molecular switch
that moves this protein from the pathways regulating cell cycle
progression to the ones involved in cell cycle arrest and sur-
vival. In particular, (ATM–Chk2) phosphorylated-Che-1/AATF
relocates from E2F1-dependent promoters to the promoters of
genes involved in checkpoint activation such as TP53 and p21,
thus allowing their transcription and cell cycle arrest at the G2/M
checkpoint (Bruno et al., 2006). Interestingly, these modiﬁca-
tions also promote a speciﬁc interaction between Che-1/AATF
and tumor suppressor p53. This binding occurs at the early stage
of the DDR and speciﬁcally directs p53 toward the transcription
of genes involved in cell cycle arrest. Notably, the two proteins
detach when DNA damage is not repairable and cells undergo
apoptosis (Desantis et al., 2015a). Evidence also shows that upon
DNA damage phosphorylated-Che-1/AATF, by ATM and Chk2,
promotes the transcription of the anti-apoptotic factor XIAP,
an inhibitor of caspase activity. Consistent with this observa-
tion, Che-1/AATF overexpression protects cells from apoptosis
induced by DNA damaging agents (Bruno et al., 2008).
It is worth remembering that, other than phosphoryla-
tion, poly(ADP-ribosyl)ation also participates in regulating Che-
1/AATF activities upon genotoxic stress. In fact, it has been
demonstrated that poly (ADP-ribose) polymerase 1 (PARP-1)
interacts with this protein and promotes its modiﬁcation, which
in turn contributes to Che-1/AATF stabilization upon DNAdam-
age (Bacalini et al., 2011).
A recent study revealed that Che-1/AATF is also part of the
spindle assembly checkpoint (SAC), a ubiquitous safety mecha-
nism that ensures the ﬁdelity of chromosome segregation during
mitosis and cooperates with the proteins of the DDR network
in restricting mitotic progression in response to DNA damage
(Zhang et al., 2007; Lara-Gonzalez et al., 2012). In particular, it
was shown that DNA damage induces centrosomal accumulation
of Che-1/AATF and depletion of this protein is associated with
an increase in the number of centrosomes, multipolar spindles,
failure to arrest mitosis, and apoptosis in response to genotoxic
treatments (Sorino et al., 2013).
In agreement with its anti-apoptotic and prosurvival roles,
Che-1/AATF degradation is required to execute the apoptotic
programwhenDNAdamage is too severe and cannot be repaired.
The complex signaling cascade that leads to Che-1/AATF degra-
dation following apoptotic DNA damage has been recently eluci-
dated in two papers from De Nicola et al. (2007). They showed
that upon apoptotic DNA damage the kinase HIPK2 directly
interacts with Che-1/AATF and phoshorylates it at residue T144.
This phosphorylation allows a conformational change medi-
ated by the prolyl isomerase Pin1, which in turn promotes the
interaction with ubiquitin ligase HDM2, thereby promoting Che-
1/AATF ubiquitylation and proteasomal degradation. In agree-
ment with these results, Che-1/AATF overexpression interferes
with HIPK2 induced apoptosis, while failure in Che-1/AATF
degradation upon apoptotic stimuli is associated with reduced
cell death (De Nicola et al., 2007, 2014).
Frontiers in Genetics | www.frontiersin.org 3 April 2015 | Volume 6 | Article 141
Iezzi and Fanciulli The multifunctional Che-1/AATF is essential for cell survival
As described above, Che-1/AATF strongly aﬀects p53 func-
tions upon DNA damage by activating its transcription, promot-
ing p53 dependent growth arrest and inhibiting p53 dependent
apoptosis. Notably, this protein has also a strong impact on the
activity of the mutant forms of p53 (mtp53), which are associ-
ated with almost 50% of cancer cases (Freed-Pastor and Prives,
2012). Indeed, Che-1/AATF is required for mtp53 transcription
and its depletion induces apoptosis, without involving any other
stimuli, in several cancer cell lines carrying mtp53. This event
is the result of a simultaneous reduction of mtp53 level and
activation of pro-apoptotic genes, such as Puma and Noxa, by
tumor suppressor protein p73. In more detail, in the presence
of mtp53, Che-1/AATF depletion induces endogenous check-
point activation that leads to stabilization of the transcription
factor E2F1, which in turn, activates p73. Inline with Che-
1/AATF’s ability to modulate checkpoint activation, Aﬀymetrix
microarray experiments have revealed that this protein regulates
the expression of genes involved in DNA repair (Bruno et al.,
2010).
Cellular Stress
Over the last few years, several pieces of evidence indicate
that Che-1/AATF participates in the cellular response to dif-
ferent types of stress, other than DNA damage (Figure 1).
For example, hyperosmotic stress can activate Che-1/AATF
by inducing MK2-mediated phosphorylation (Höpker et al.,
2012).
Ishigaki et al. (2010) indicated Che-1/AATF as a compo-
nent of the unfolded protein response (UPR), an adaptative
mechanism activated by endoplasmatic reticulum (ER) stress
whose function is to restore ER homeostasis or induce apopto-
sis if stress cannot be resolved. Che-1/AATF is induced upon
ER stress and promotes cell survival by activating transcrip-
tion on the serine/threonine kinase AKT1, through directly
interacting with transcription factor STAT3. Indeed, ectopic
expression of Che-1/AATF protects cells from ER stress medi-
ated apoptosis whereas its depletion increases the percentage
of apoptotic cells after induction of ER stress (Ishigaki et al.,
2010).
More recently, it has been demonstrated that Che-1/AATF
protects cells from apoptosis induced by ionizing radiations (IR),
hypoxia, or glucose deprivation by inducing autophagy, a self
degradative process essential for maintaining cellular homeosta-
sis that allows cells to survive under metabolic stress. In par-
ticular, Che-1/AATF inhibits the activity of the kinase mTOR,
a central regulator of autophagy, by activating the transcription
of its inhibitors Redd1 and Deptor. In agreement with these
results, Che-1/AATF depletion decreases autophagy induction
after stress, thus leading to apoptosis (Desantis et al., 2015b).
Interestingly, it has been recently reported that inhibition of
serum deprivation induced autophagy by resveratrol reduces
phosphorylation of Che-1/AATF at residues S316, S320, and
S321; however, the kinases responsible of these modiﬁcations are
still unknown (Alayev et al., 2014).
FIGURE 1 | Che-1/AATF is a central mediator of the cellular response to different types of stress. In response to DNA damage and cellular stress
Che-1/AATF promotes cell survival by inducing cell cycle arrest, autophagy, DNA repair and inhibition of apoptosis. Otherwise if DNA damage is too severe
Che-1/AATF is degradated and cells undergo apoptosis. ER, endoplasmatic reticulum.
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Che-1/AATF as a Putative Therapeutic
Target in Cancer
Overall, the observations described above strongly indicate that
Che-1/AATF plays an important role in many aspects of can-
cer biology. Indeed, this protein is not only involved in cell
cycle progression and in protecting cancer cells from apopto-
sis induction, but also plays a role in controlling autophagic
response and ER stress, appearing to be able to sustain the
survival of tumor cells (Desantis et al., 2015b). Moreover, Che-
1/AATF deeply aﬀects the activity of p53, by both modulating
wild type p53 target speciﬁcity and supporting the “gain of func-
tion” of the mutated forms of this oncosuppressor (Bruno et al.,
2010; Desantis et al., 2015a). However, a screening for Che-
1/AATF mutations in 121 breast cancer families has highlighted
that no mutations in Che-1/AATF coding sequence can be asso-
ciated with cancer predisposition (Haanpää et al., 2009). On the
other hand, several studies suggest that dysregulation in Che-
1/AATF level inside cells could be relevant for the transformation
process. In fact, this protein has been found upregulated in
several leukemia cell lines and in patients with chronic lympho-
cytic leukemia (Kaul and Mehrotra, 2007; Bacalini et al., 2012).
In addition, Che-1/AATF gene was ampliﬁed in neuroblastoma
patients and increased Che-1/AATF expression levels were asso-
ciated with poor prognosis and reduced survival (Höpker et al.,
2012). Consistent with these observations, Che-1/AATF deple-
tion was shown to enhance the cytotoxic eﬀect of DNA-damaging
chemotherapy both in vitro and in vivo and to induce apop-
tosis of cancer cells carrying mtp53 (Bruno et al., 2006, 2008,
2010; Höpker et al., 2012). All these ﬁndings strengthen the
notion that Che-1/AATF could be considered a valid target for
novel anticancer therapeutic approaches. Unfortunately, so far
no compounds able to inhibit Che-1/AATF activity have been
identiﬁed. However, future eﬀorts focused on understanding the
mechanism of action of Che-1/AATF and the characterization
of the pathways implicated in its regulation will provide use-
ful indications towards developing speciﬁc inhibitors for this
protein.
Concluding Remarks and Open
Questions
Much has been learned about Che-1/AATF functions in the
years following its identiﬁcation but a great deal remains to be
unveiled.
One question that needs to be addressed is its role in DNA
repair. Bruno et al. (2010) have shown that Che-1/AATF expres-
sion is necessary for proper repair of damaged DNA, but how
this action is exerted is still not entirely understood. The abil-
ity of Che-1/AATF to regulate the expression of genes involved
in DNA repair is deﬁnitely part of this process but other mech-
anisms may participate. At the structural level, one of the main
features of Che-1/AATF is the presence of an extremely acidic
domain at its N-terminal region, which in other transcription
factors has been associated with chromatin remodeling prop-
erties (Hu et al., 1999; Tumbar et al., 1999). Moreover, Che-
1/AATF has been found in histone acetyltransferase complexes
through its interaction with the transcriptional co-activator
ADA3 (Zencir et al., 2013) and it has the ability to induce local
histone hyperacetylation by displacing HDAC1 from transcrip-
tion factors pRb and Sp1 (Bruno et al., 2002; Di Padova et al.,
2003). Based on these observations, one could speculate that
Che-1/AATF participates in the DNA repair process by regu-
lating the chromatin state and increasing its accessibility. If so,
a new scenario for Che-1/AATF functions will be open since
chromatin remodeling plays a fundamental role in replicative
and transcriptional controls. Indeed, Che-1/AATF could partic-
ipate in the regulation of gene expression by regulating chro-
matin structure at speciﬁc gene loci where it is recruited by its
interaction with both transcription factors and transcriptional
machinery.
Furthermore, since Che-1/AATF has already been appointed
as a nucleolar stress sensor (Ferraris et al., 2012), it will be inter-
esting to further investigate its involvement in the nucleolar
stress response that monitors and maintains ribosome biogen-
esis and nucleolar integrity. This pathway has a crucial role
in maintaining cellular homeostasis and it has been demon-
strated that nucleoli disruption leads to activation of p53 in
absence of DNA damage (Rubbi and Milner, 2003). Moreover,
transformed cells undergo p53 mediated senescence, autophagy,
and apoptosis in response to nucleolar perturbation by inhibi-
tion of ribosomal RNA synthesis (Woods et al., 2014). Indeed,
in the last few years nucleolus and ribosomal gene expression
are emerging as new exciting targets for cancer therapy and
RNA polymerase I inhibitors are currently entering phase I
clinical trials (Quin et al., 2014). In this context, it will be fun-
damental to explore the possibility that Che-1/AATF plays a
role in ribosome biogenesis itself. This idea is supported by the
observations that a mouse embryo mutant for Traube shows
a decrease in the number of ribosomes and Drosophila Che-
1/AATF mutants arrest the development of the egg chamber at
the same stage as the mutants aﬀecting the synthesis of ribo-
somes, namely when the massive growth starts and cells need
to synthesize ribosomes to trigger this growth (Jagut et al.,
2013).
Answering these questions will shed further light on additional
aspects of Che-1/AATF functions and likely contribute to identi-
fying possible therapeutic approaches involving this protein.
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